Epigenetic silencing of BEND4 unveils new path for PDAC treatment
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as ...
Tag: Cancer Treatment
NCCN leaders collaborate to enhance cancer care in Vietnam
As part of ongoing work to define and advance high-quality cancer care globally, leaders from the National Comprehensive Cancer Network® ...
Scientists map the genetic landscape of drug resistance in cancers
All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping ...
Common breast cancer therapies may speed up aging, study shows
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including ...
Researchers reveal mechanisms of how CDK12 alterations drive prostate cancer development
When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew ...
New drug could extend the lives of breast cancer patients
LMU researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients. Patients with ...
Immunotherapy timing key to survival in small cell lung cancer treatment
People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are ...
UCLA Health researchers showcase advances in radiation oncology at ASTRO
UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation therapies will present data ...
Key enzyme identified as potential target for cancer treatment
During every moment of any living organism's life, enzymes are at work. These crucial proteins support life through most biological ...
Five key factors identified for predicting immunotherapy response in cancer patients
Immunotherapy has transformed cancer treatment in recent years by enabling the immune system to attack tumor cells. However, only 20-40% ...
POPULAR NEWS
